PhOx430 clinical trials

First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours

This study tests an investigational drug called PhOx430 for advanced cancers that haven't responded to other treatments. It aims to find a safe dose and see how well it works, especially in certain types of solid tumours.